These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 22548488)
1. Combination of Caspy2 and IP-10 gene therapy significantly improves therapeutic efficacy against murine malignant neoplasm growth and metastasis. Zhang N; Yang Y; Cheng L; Zhang XM; Zhang S; Wang W; Liu SY; Wang SY; Wang RB; Xu WJ; Dai L; Yan N; Fan P; Dai LX; Tian HW; Liu L; Deng HX Hum Gene Ther; 2012 Aug; 23(8):837-46. PubMed ID: 22548488 [TBL] [Abstract][Full Text] [Related]
2. IL15 combined with Caspy2 provides enhanced therapeutic efficiency against murine malignant neoplasm growth and metastasis. Yang Y; Zhang XM; Zhang N; Cheng L; Li C; Zhang S; Zhang JF; Dai L; Tian HW; Yan N; Fan P; Dai LX; Xu F; Shi G; Chen XL; Du T; Li YM; Wei YQ; Deng HX Cancer Gene Ther; 2012 Jul; 19(7):460-7. PubMed ID: 22539063 [TBL] [Abstract][Full Text] [Related]
3. Combination of DESI2 and endostatin gene therapy significantly improves antitumor efficacy by accumulating DNA lesions, inducing apoptosis and inhibiting angiogenesis. Yan H; Guo W; Li K; Tang M; Zhao X; Lei Y; Nie CL; Yuan Z Exp Cell Res; 2018 Oct; 371(1):50-62. PubMed ID: 30055135 [TBL] [Abstract][Full Text] [Related]
4. A novel strategy for tumour therapy combining cell apoptosis and active immunity induced by caspy2, a zebrafish caspase. Liu L; Deng H; Wang Y; Chen P; Yang Y; Yang H; Chen X; Chen L; Zhu W; Liang S; Yang J; Qian Z; Li J; Wen Y; Kan B; Mao Y; Zhao X; Wei Y J Cell Mol Med; 2009 Aug; 13(8B):2271-2281. PubMed ID: 19220579 [TBL] [Abstract][Full Text] [Related]
5. Efficient inhibition of ovarian cancer by recombinant CXC chemokine ligand 10 delivered by novel biodegradable cationic heparin-polyethyleneimine nanogels. Yang F; Gou M; Deng H; Yi T; Zhong Q; Wei Y; Zhao X Oncol Rep; 2012 Aug; 28(2):668-76. PubMed ID: 22684947 [TBL] [Abstract][Full Text] [Related]
6. NK and CD8+ T cell-mediated eradication of poorly immunogenic B16-F10 melanoma by the combined action of IL-12 gene therapy and 4-1BB costimulation. Xu D; Gu P; Pan PY; Li Q; Sato AI; Chen SH Int J Cancer; 2004 Apr; 109(4):499-506. PubMed ID: 14991570 [TBL] [Abstract][Full Text] [Related]
7. The therapeutic potential of human adipose-derived mesenchymal stem cells producing CXCL10 in a mouse melanoma lung metastasis model. Mirzaei H; Salehi H; Oskuee RK; Mohammadpour A; Mirzaei HR; Sharifi MR; Salarinia R; Darani HY; Mokhtari M; Masoudifar A; Sahebkar A; Salehi R; Jaafari MR Cancer Lett; 2018 Apr; 419():30-39. PubMed ID: 29331419 [TBL] [Abstract][Full Text] [Related]
8. Combination of interleukin 12 and interferon alpha gene therapy induces a synergistic antitumor response against colon and renal cell carcinoma. Mendiratta SK; Quezada A; Matar M; Thull NM; Bishop JS; Nordstrom JL; Pericle F Hum Gene Ther; 2000 Sep; 11(13):1851-62. PubMed ID: 10986558 [TBL] [Abstract][Full Text] [Related]
9. Improved therapeutic effectiveness by combining recombinant CXC chemokine ligand 10 with Cisplatin in solid tumors. Li G; Tian L; Hou JM; Ding ZY; He QM; Feng P; Wen YJ; Xiao F; Yao B; Zhang R; Peng F; Jiang Y; Luo F; Zhao X; Zhang L; Zhou Q; Wei YQ Clin Cancer Res; 2005 Jun; 11(11):4217-24. PubMed ID: 15930360 [TBL] [Abstract][Full Text] [Related]
10. The enhanced anti-angiogenic and antitumor effects of combining flk1-based DNA vaccine and IP-10. Lu XL; Jiang XB; Liu RE; Zhang SM Vaccine; 2008 Oct; 26(42):5352-7. PubMed ID: 18723067 [TBL] [Abstract][Full Text] [Related]
11. Forced Expression of CXCL10 Prevents Liver Metastasis of Colon Carcinoma Cells by the Recruitment of Natural Killer Cells. Kikuchi N; Ye J; Hirakawa J; Kawashima H Biol Pharm Bull; 2019 Jan; 42(1):57-65. PubMed ID: 30381616 [TBL] [Abstract][Full Text] [Related]
12. Folate-modified Chitosan Nanoparticles Containing the IP-10 Gene Enhance Melanoma-specific Cytotoxic CD8(+)CD28(+) T Lymphocyte Responses. He J; Duan S; Yu X; Qian Z; Zhou S; Zhang Z; Huang X; Huang Y; Su J; Lai C; Meng J; Zhou N; Lu X; Zhao Y Theranostics; 2016; 6(5):752-61. PubMed ID: 27022421 [TBL] [Abstract][Full Text] [Related]
13. Combination of DESI2 and IP10 gene therapy significantly improves therapeutic efficacy against murine carcinoma. Lin C; Yan H; Yang J; Li L; Tang M; Zhao X; Nie C; Luo N; Wei Y; Yuan Z Oncotarget; 2017 Aug; 8(34):56281-56295. PubMed ID: 28915590 [TBL] [Abstract][Full Text] [Related]
14. Anti-tumor immunity induced by in vivo adenovirus vector-mediated expression of CD40 ligand in tumor cells. Kikuchi T; Crystal RG Hum Gene Ther; 1999 May; 10(8):1375-87. PubMed ID: 10365667 [TBL] [Abstract][Full Text] [Related]
15. Synergic antitumor effect of SKLB1002 and local hyperthermia in 4T1 and CT26. Nie W; Ma XL; Sang YX; Li YL; Gao X; Xu GC; Shen GB; Shi HS; Liu XX; Wang FT; Wei YQ Clin Exp Med; 2014 May; 14(2):203-13. PubMed ID: 23263406 [TBL] [Abstract][Full Text] [Related]
16. Antitumor effect of mSurvivinThr34→Ala in murine colon carcinoma when administered intravenously. Li HX; Zhao XY; Wang L; Wang YS; Kan B; Xu JR; Li J; Wen YJ; Peng XC; Chen X; Yan F; Ye B; Du XB; Zhao JM; Yi T; Chen XC; Du XX; Wei YQ; Zhao X Med Oncol; 2010 Dec; 27(4):1156-63. PubMed ID: 19949901 [TBL] [Abstract][Full Text] [Related]
17. Adenovirus-mediated lymphotactin gene transfer improves therapeutic efficacy of cytosine deaminase suicide gene therapy in established murine colon carcinoma. Ju DW; Tao Q; Cheng DS; Zhang W; Zhang M; Hamada H; Cao X Gene Ther; 2000 Feb; 7(4):329-38. PubMed ID: 10694814 [TBL] [Abstract][Full Text] [Related]
19. Sonodynamic therapy improves anti‑tumor immune effect by increasing the infiltration of CD8+ T cells and altering tumor blood vessels in murine B16F10 melanoma xenograft. Peng Y; Jia L; Wang S; Cao W; Zheng J Oncol Rep; 2018 Oct; 40(4):2163-2170. PubMed ID: 30106435 [TBL] [Abstract][Full Text] [Related]
20. Combined vaccination with major histocompatibility class I and interleukin 2 gene-transduced melanoma cells synergizes the cure of postsurgical established lung metastases. Porgador A; Tzehoval E; Vadai E; Feldman M; Eisenbach L Cancer Res; 1995 Nov; 55(21):4941-9. PubMed ID: 7585534 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]